← FDA Drug Approvals (Drugs@FDA)
CLOBETASOL PROPIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK SPECLT · Approved 2017-03-20
Drug application
- FDA Application #
ANDA208933
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CLOBETASOL PROPIONATE
- Generic name
- CLOBETASOL PROPIONATE
- Active ingredients
- CLOBETASOL PROPIONATE
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Marketing status
- Discontinued
- Sponsor
- GLENMARK SPECLT
- Manufacturer
- Northstar Rx LLC
- First approval
- 2017-03-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown